DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Parving HH, Lehnert H, Brochner-Mortensen J. et al.
Irbesartan in Patients with Type 2 Diabetes
and Microalbuminuria Study Group. The effect of irbesartan on the
development of diabetic nephropathy in patients with type 2 diabetes.
N Engl J Med 2001; 345: 870-878
We do not assume any responsibility for the contents of the web pages of other providers.